(Neo-)Adjuvante Therapie beim Magenkarzinom

Schlüsselwörter

Magenkarzinom - neoadjuvante Therapie - Chemotherapie - Chemoradiotherapie

Keywords

gastric cancer - neoadjuvant treatment - chemotherapy - chemoradiotherapy

• Literatur

• 1 Cunningham D, Allum WH, Stenning SP et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355: 11-20
• 2 Moehler M, Al-Batran SE, Andus T et al. S3-Leitlinie „Magenkarzinom“ – Diagnostik und Therapie der Adenokarzinome des Magens und ösophagogastralen Übergangs (AWMF-Regist.-Nr. 032-009-OL). Z Gastroenterol 2011; 49: 461-531
• 3 Möhler M, Siveke JT, Schmid RM. Magenkarzinom – Was gibt’s Neues?. Dtsch Med Wochenschr 2011; 136: 2492-2495
• 4 Paoletti X, Oba K, Burzykowski T et al. Benefit of adjuvant chemotherapy für resectable gastric cancer: a meta-analysis. JAMA 2010; 303: 1729-1737
• 5 Schuhmacher C, Gretschel S, Lordick F et al. Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954. J Clin Oncol 2010; 28: 52105218
• 6 Stahl M, Walz MK, Stuschke M et al. Phase III Comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 2009; 27: 851-856
• 7 Ychou M, Boige V, Pignon JP et al. Perioperative Chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter Phase III trial. J Clin Oncol 2011; 29: 1715-1721